Making Sense of NICE Guidance for Bowel Care

Benefits for your practice and patients

Discover the Bowel Interest Group’s latest report

Jan 16, 2023

This report describes how following NICE guidance can support healthcare professionals by producing contemporary evidence-based patient care recommendations, as well as delivery of service improvements.

‘Making Sense of NICE Guidance for Bowel Care’ confronts the challenge of keeping up to date with ever-expanding medical literature while managing large workloads.

Given BIG’s area of expertise, this report centres on the value of NICE guidance in the field of bowel care, but the messages are applicable to the widest range of healthcare. 


  • A foreword from Professor Anton Emmanuel
  • NICE: An overview
  • The importance of following NICE guidelines
  • How NICE guidelines are developed
  • Tackling the challenges and NICE’s future strategy
  • Case studies relating to bowel care

“Healthcare professionals face a range of challenges. Clinical workloads are increasing both in primary and secondary care. Funding of healthcare is under strain as never before. Coupled with staff shortages, this is placing increasing constraints on the opportunities available for healthcare professionals to keep abreast of the rapidly advancing medical literature”.

The Bowel Interest Group (BIG) is a multi-disciplinary group dedicated to raising the profile of bowel management. The group provides evidence driven educational resources to support healthcare professionals treating patients with bowel conditions.  

BIG is owned by E4H Ltd. BIG works in collaboration with organisations who share the aim of improving bowel care for patients. This includes commercial organisations as well as other professional societies or charities. BIG’s supporters provide funding for meetings of the expert group and for the services of E4H to provide secretariat support to the group. The supporters have no editorial control over the content of expert group materials except for reviewing the materials to ensure compliance with industry codes of ethical conduct. Please find out more about our supporters on our website

The Bowel Interest Group has received funding for this report from Coloplast. Coloplast have had no editorial control over this report.